Initiation of confirmatory Phase 3 trial with roluperidone for negative symptoms of schizophrenia is planned for Q2 2026, with topline data anticipated in 2H 2027BURLINGTON, Mass., March 11, 2026 (GLO ...
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing product candidates to treat CNS diseases. Minerva is initiating a confirmatory Phase 3 trial with ...
Daily Voice on MSN
Ed, Beata Myles's professional home services sued by PA AG
A home builder already ordered to repay more than $500,000 to consumers is facing a new lawsuit after allegedly transferring properties to relatives for just $1 each, Pennsylvania Attorney General ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results